Introduction Several programmed death ligand-1 (PD1/L1) immune checkpoint inhibitors
(ICIs) are approved in urothelial carcinoma (UC). Patients and Methods To address the need …

The relationship between smoking, ethnicity and bladder cancer is complex and
multifaceted, with substantial public and personal health as well as clinical implications …

Objective To quantify the differences in 5‐year overall survival (OS) between high‐grade
(Gleason sum 8–10) incidental prostate cancer (IPCa) patients and age‐matched male …

Purpose To assess whether 5‐year overall survival (OS) of squamous cell carcinoma of the
penis (SCCP) patients differs from age‐matched male population‐based controls. Methods …

Background It is unknown whether 5‐year overall survival (OS) differs and to what extent
between the American Joint Committee on Cancer stage III non‐seminoma testicular germ …

Introduction Collecting duct carcinoma (CDC) is a rare renal malignancy. We relied on a
large population-based cohort to address epidemiology, clinical characteristics, and …

Introduction Trimodal therapy (TMT) is the most validated bladder-sparing treatment for
organ-confined urothelial carcinoma of the urinary bladder (OC UCUB, namely cT2N0M0) …

Purpose To quantify differences in five-year overall survival (OS) between clear cell
metastatic renal cell carcinoma (ccmRCC) patients and age-and sex-matched population …

Objective To describe patient characteristics and pathological stage at bladder cancer (BCa)
diagnosis in a diverse population within a national, equal‐access healthcare system …

Purpose It is unknown to what extent overall survival (OS) of organ-confined (T2N0M0)
urothelial carcinoma of the urinary bladder (UCUB) patients differs from age-and sex …